Use of Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Has Doubled
Use of neoadjuvant chemotherapy for patients with stage IIIC and IV epithelial ovarian cancer has increased from 2004 to 2016.
Diagnosis & Disease Information
Hyperthermic Intraperitoneal Chemotherapy May Improve Outcomes in Epithelial Ovarian Cancer
Hyperthermic intraperitoneal chemotherapy added to cytoreductive surgery improved outcomes compared with surgery alone in a cohort study.
Rapid Third-Infusion Protocol of Daratumumab in Patients With Relapsed/Refractory Multiple Myeloma
An observational study determined that 90-minute rapid infusions of daratumumab for RRMM was safe and well-tolerated.
Weight and Swallowing-Related Quality of Life in Patients Treated for Oropharyngeal Cancer
Single-center study reports on the effects of oropharyngeal cancer treatment at 3, 6, and 12 months after chemoradiotherapy or radiotherapy alone, and with and without a feeding tube.
Hearing Loss Associated With Neurocognitive Deficits in Pediatric Cancer Survivors, Study Finds
A large cross-sectional cohort study investigated the relationship between hearing loss and measures of neurocognition in survivors of childhood cancers.
Reducing Time to Alkalinization Prior to HD-MTX Does Not Reduce Hospital Length of Stay
Adding acetazolamide reduced time to alkalinization, allowing for earlier administration of high-dose methotrexate; however, it did not reduce overall hospital length of stay.
New Evidence Supports Update of ASCO Guidelines on Prevention, Treatment of CIPN
A literature search of new studies clarifies, refutes, and expands on previous recommendations for managing new and established CIPN in patients treated with cytotoxic agents.
Routine Use of Neoadjuvant Docetaxel Plus ADT Not Supported in Localized, High-Risk Prostate Cancer
Patients with localized prostate cancer characterized by high-risk features are at increased risk of a negative outcome following radical prostatectomy.
Assessing Barriers and Facilitators of Timely Chemotherapy Delivery in the Ambulatory Care Setting
Researchers examined causes of avoidable chemotherapy delays as a means of improving the quality of care for outpatients receiving chemotherapy.
Pilot Program Shows That Remote Intensive Monitoring in High-Risk Patients May Improve Outpatient Symptom Management
Using remote communications technology, a major cancer center was able to manage symptoms in high-risk patients initiating treatment at a regional location.
- Loading...
Loading...
Next post in ASCO 2020
Loading... 
Loading...